Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Bhojwani

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemiaDeepa Bhojwani, Noah D Sabin, Deqing Pei, et al.
Pediatric Blood & Cancer|January 17, 2020
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemiaNirali N Shah, Deepa Bhojwani, Keith August, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaArend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, et al.
Blood Neoplasia|June 30, 2026
Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium reportEric S Schafer, Holly L Pacenta, Yueh-Yun Chi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Improved prognosis for older adolescents with acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, Dario Campana, et al.
British Journal of Haematology|June 26, 2024
Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group StudyStavroula Anastasopoulou, Gemma Swann, Liv Andres-Jensen, et al.
Blood|November 3, 2009
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaHuining Kang, I-Ming Chen, Carla S Wilson, et al.
Genome Research|December 2, 2016
Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBPMaoxiang Qian, Hui Zhang, Shirley Kow-Yin Kham, et al.
Blood Advances|July 14, 2022
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapyEmily M Hsieh, Regina M Myers, Bonnie Yates, et al.
Nature Reviews. Clinical Oncology|January 23, 2026
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancerLiora Schultz, Kevin McNerney, Adam J Lamble, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemiaDeepa Bhojwani, Noah D Sabin, Deqing Pei, et al.
Pediatric Blood & Cancer|January 17, 2020
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemiaNirali N Shah, Deepa Bhojwani, Keith August, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaArend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, et al.
Blood Neoplasia|June 30, 2026
Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium reportEric S Schafer, Holly L Pacenta, Yueh-Yun Chi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Improved prognosis for older adolescents with acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, Dario Campana, et al.
British Journal of Haematology|June 26, 2024
Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group StudyStavroula Anastasopoulou, Gemma Swann, Liv Andres-Jensen, et al.
Blood|November 3, 2009
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaHuining Kang, I-Ming Chen, Carla S Wilson, et al.
Genome Research|December 2, 2016
Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBPMaoxiang Qian, Hui Zhang, Shirley Kow-Yin Kham, et al.
Blood Advances|July 14, 2022
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapyEmily M Hsieh, Regina M Myers, Bonnie Yates, et al.
Nature Reviews. Clinical Oncology|January 23, 2026
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancerLiora Schultz, Kevin McNerney, Adam J Lamble, et al.
Pageof 13